BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36520054)

  • 21. RBM17 controls apoptosis and proliferation to promote Glioma progression.
    Lu J; Li Q; Cai L; Zhu Z; Guan J; Wang C; Xia J; Xia L; Wen M; Zheng W; Su Z; Wang C
    Biochem Biophys Res Commun; 2018 Oct; 505(1):20-28. PubMed ID: 30227940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short hairpin RNA- mediated gene knockdown of FOXM1 inhibits the proliferation and metastasis of human colon cancer cells through reversal of epithelial-to-mesenchymal transformation.
    Yang K; Jiang L; Hu Y; Yu J; Chen H; Yao Y; Zhu X
    J Exp Clin Cancer Res; 2015 May; 34(1):40. PubMed ID: 25935853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FOXM1 modulates 5-FU resistance in colorectal cancer through regulating TYMS expression.
    Varghese V; Magnani L; Harada-Shoji N; Mauri F; Szydlo RM; Yao S; Lam EW; Kenny LM
    Sci Rep; 2019 Feb; 9(1):1505. PubMed ID: 30728402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of an AKT/FOXM1/STMN1 pathway drives resistance to tyrosine kinase inhibitors in lung cancer.
    Li M; Yang J; Zhou W; Ren Y; Wang X; Chen H; Zhang J; Chen J; Sun Y; Cui L; Liu X; Wang L; Wu C
    Br J Cancer; 2017 Sep; 117(7):974-983. PubMed ID: 28850563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gambogic Acid Efficiently Kills Stem-Like Colorectal Cancer Cells by Upregulating ZFP36 Expression.
    Wei F; Zhang T; Yang Z; Wei JC; Shen HF; Xiao D; Wang Q; Yang P; Chen HC; Hu H; Chen ZP; Huang Q; Li WL; Cao J
    Cell Physiol Biochem; 2018; 46(2):829-846. PubMed ID: 29627822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downregulation of FOXO3a by DNMT1 promotes breast cancer stem cell properties and tumorigenesis.
    Liu H; Song Y; Qiu H; Liu Y; Luo K; Yi Y; Jiang G; Lu M; Zhang Z; Yin J; Zeng S; Chen X; Deng M; Jia X; Gu Y; Chen D; Zheng G; He Z
    Cell Death Differ; 2020 Mar; 27(3):966-983. PubMed ID: 31296961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Co-targeting of Cyclooxygenase-2 and FoxM1 is a viable strategy in inducing anticancer effects in colorectal cancer cells.
    Ahmed M; Hussain AR; Siraj AK; Uddin S; Al-Sanea N; Al-Dayel F; Al-Assiri M; Beg S; Al-Kuraya KS
    Mol Cancer; 2015 Jul; 14():131. PubMed ID: 26159723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Silencing transcription factor FOXM1 represses proliferation, migration, and invasion while inducing apoptosis of liver cancer stem cells by regulating the expression of ALDH2.
    Chen L; Wu M; Ji C; Yuan M; Liu C; Yin Q
    IUBMB Life; 2020 Feb; 72(2):285-295. PubMed ID: 31580537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical value and potential association of Rab1A and FoxM1 aberrant expression in colorectal cancer.
    Xu M; Shao X; Li H; Zhang Z; Zhou C; Cheng Z
    Sci Rep; 2020 Nov; 10(1):20160. PubMed ID: 33214609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dysregulation of miR-6868-5p/FOXM1 circuit contributes to colorectal cancer angiogenesis.
    Wang Y; Wu M; Lei Z; Huang M; Li Z; Wang L; Cao Q; Han D; Chang Y; Chen Y; Liu X; Xue L; Mao X; Geng J; Chen Y; Dai T; Ren L; Wang Q; Yu H; Chen C; Chu X
    J Exp Clin Cancer Res; 2018 Nov; 37(1):292. PubMed ID: 30486864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TRIM6 promotes colorectal cancer cells proliferation and response to thiostrepton by TIS21/FoxM1.
    Zheng S; Zhou C; Wang Y; Li H; Sun Y; Shen Z
    J Exp Clin Cancer Res; 2020 Jan; 39(1):23. PubMed ID: 31992359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Co-inhibition of BET proteins and NF-κB as a potential therapy for colorectal cancer through synergistic inhibiting MYC and FOXM1 expressions.
    Wu T; Wang G; Chen W; Zhu Z; Liu Y; Huang Z; Huang Y; Du P; Yang Y; Liu CY; Cui L
    Cell Death Dis; 2018 Feb; 9(3):315. PubMed ID: 29472532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FOXM1 expression correlates with tumor invasion and a poor prognosis of colorectal cancer.
    Chu XY; Zhu ZM; Chen LB; Wang JH; Su QS; Yang JR; Lin Y; Xue LJ; Liu XB; Mo XB
    Acta Histochem; 2012 Dec; 114(8):755-62. PubMed ID: 22326401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-346-5p promotes colorectal cancer cell proliferation in vitro and in vivo by targeting FBXL2 and activating the β-catenin signaling pathway.
    Pan S; Wu W; Ren F; Li L; Li Y; Li W; Wang A; Liu D; Dong Y
    Life Sci; 2020 Mar; 244():117300. PubMed ID: 31953162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genome-wide expression analysis of Middle Eastern colorectal cancer reveals FOXM1 as a novel target for cancer therapy.
    Uddin S; Ahmed M; Hussain A; Abubaker J; Al-Sanea N; AbdulJabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Jehan Z; Bavi P; Siraj AK; Al-Kuraya KS
    Am J Pathol; 2011 Feb; 178(2):537-47. PubMed ID: 21281787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LncRNA MCF2L-AS1 aggravates proliferation, invasion and glycolysis of colorectal cancer cells via the crosstalk with miR-874-3p/FOXM1 signaling axis.
    Zhang Z; Yang W; Li N; Chen X; Ma F; Yang J; Zhang Y; Chai X; Zhang B; Hou X; Luo S; Hua Y
    Carcinogenesis; 2021 Feb; 42(2):263-271. PubMed ID: 32860508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Interaction of GLUT1 and FOXM1 Leads to a Poor Prognosis in Colorectal Cancer.
    Kuai XY; Lei ZY; Liu XS; Shao XY
    Anticancer Agents Med Chem; 2020; 20(8):941-950. PubMed ID: 32188390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sequential Treatment with Activin and Hepatocyte Growth Factor Induces FOXM1 to Promote Colorectal Cancer Liver Metastasis.
    Peng H; Ye T; Deng L; Yang X; Jiang Z; Guo J
    Can J Gastroenterol Hepatol; 2022; 2022():8996203. PubMed ID: 36591565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isovitexin reduces carcinogenicity and stemness in hepatic carcinoma stem-like cells by modulating MnSOD and FoxM1.
    Cao X; Liu L; Yuan Q; Li X; Cui Y; Ren K; Zou C; Chen A; Xu C; Qiu Y; Quan M; Zhang J; Cao J; Chen X
    J Exp Clin Cancer Res; 2019 Jun; 38(1):264. PubMed ID: 31208440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpressed transcription factor FOXM1 contributes to the progression of colorectal cancer.
    Zhang H; Zhong H; Li L; Ji W; Zhang X
    Mol Med Rep; 2016 Mar; 13(3):2696-700. PubMed ID: 26861549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.